Literature DB >> 27076648

Exercise-induced albuminuria is related to metabolic syndrome.

Sharon Greenberg1, Shani Shenhar-Tsarfaty2, Ori Rogowski3, Itzhak Shapira4, David Zeltser5, Talia Weinstein6, Dror Lahav2, Jaffa Vered2, Oholi Tovia-Brodie4, Yaron Arbel4, Shlomo Berliner2, Assi Milwidsky2.   

Abstract

Microalbuminuria (MA) is a known marker for endothelial dysfunction and future cardiovascular events. Exercise-induced albuminuria (EiA) may precede the appearance of MA. Associations between EiA and metabolic syndrome (MS) have not been assessed so far. Our aim was to investigate this association in a large sample of apparently healthy individuals with no baseline albuminuria. This was a cross-sectional study of 2,027 adults with no overt cardiovascular diseases who took part in a health survey program and had no baseline MA. Diagnosis of MS was based on harmonized criteria. All patients underwent an exercise test (Bruce protocol), and urinary albumin was measured before and after the examination. Urinary albumin-to-creatinine ratio (ACR) values before and after exercise were 0.40 (0.21-0.89) and 1.06 (0.43-2.69) mg/g for median (interquartile range) respectively. A total of 394 (20%) subjects had EiA; ACR rose from normal rest values (0.79 mg/g) to 52.28 mg/g after exercise (P < 0.001); this effect was not shown for the rest of the study population. EiA was related to higher prevalence of MS (13.8% vs. 27.1%, P < 0.001), higher metabolic equivalents (P < 0.001), higher baseline blood pressure (P < 0.001), and higher levels of fasting plasma glucose, triglycerides, and body mass index (P < 0.001). Multivariate binary logistic regression model showed that subjects with MS were 98% more likely to have EiA (95% confidence interval: 1.13-3.46, P = 0.016). In conclusion, EiA in the absence of baseline MA is independently related to MS.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  exercise-induced albuminuria; metabolic syndrome; stress test

Mesh:

Substances:

Year:  2016        PMID: 27076648     DOI: 10.1152/ajprenal.00481.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Hypertension is associated with increased post-exercise albuminuria, which may be attenuated by an active lifestyle.

Authors:  Ayelet Grupper; Michal Ehrenwald; Doron Schwartz; Shlomo Berliner; Moshe Shashar; Roni Baruch; Idit F Schwartz; Ori Rogowski; David Zeltser; Itzhak Shapira; Shani Shenhar-Tsarfaty
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-08       Impact factor: 3.738

2.  Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings.

Authors:  Rafael Y Brzezinski; Inbal Etz-Hadar; Ayelet Grupper; Michal Ehrenwald; Itzhak Shapira; David Zeltser; Shlomo Berliner; Ori Rogowski; Roy Eldor; Shani Shenhar-Tsarfaty
Journal:  Cardiovasc Diabetol       Date:  2017-06-23       Impact factor: 9.951

3.  Familial history of heart disease and increased risk for elevated troponin in apparently healthy individuals.

Authors:  Noa Cohen; Rafael Y Brzezinski; Michal Ehrenwald; Itzhak Shapira; David Zeltser; Shlomo Berliner; Shani Shenhar-Tsarfaty; Assi Milwidsky; Ori Rogowski
Journal:  Clin Cardiol       Date:  2019-06-07       Impact factor: 2.882

4.  Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism.

Authors:  Rafael Y Brzezinski; Limor Friedensohn; Itzhak Shapira; David Zeltser; Ori Rogowski; Shlomo Berliner; Ayelet Grupper; Shani Shenhar-Tsarfaty
Journal:  Cardiovasc Diabetol       Date:  2020-06-15       Impact factor: 9.951

5.  A second C-reactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP.

Authors:  Ilan Goldberg; Dana Shalmon; Ronen Shteinvil; Shlomo Berliner; Yael Paran; David Zeltser; Itzhak Shapira; Shani Shenhar-Tsarfaty; Ahuva Meilik; Asaf Wasserman; Ilana Goldiner; Tomer Ziv-Baran; Eli Sprecher; Tal Levinson; Ori Rogowski
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.